·   Log in

Archive for September 9th, 2009

Biocon, Dr Reddy’s, Reliance Life, Intas to dominate $19.4 bn global biosimilars market by 2014

Wednesday, September 9, 2009 14:47

Biosimilars market will grow at CAGR of 89.1% from 2009; Erythropoetin to emerge key biogeneric with $6.2 b sales: Report

This was posted under category: Biotech, Featured  |  Read Full Story  |  0 Comments

Allergan to seek approval for botulinum toxin (Botox) to cure chronic migarine headache

Wednesday, September 9, 2009 13:14

Botox therapy reduced the number of headache episodes and the number of headache days, studies found Botox, which uses botulinum toxin as active drug, could become a therapy to cure chronic migraine.

This was posted under category: health  |  Read Full Story  |  1 Comment

Pfizer, Dr Reddy’s, Serum, Jubilant among winners of Frost & Sullivan healthcare awards 2009

Wednesday, September 9, 2009 10:27

Indian arm of Pfizer Inc, Merck and desi companies including Dr Reddy's, Jubilant Organosys, Serum Institute, Veeda Clinical research are among the 19 companies from the medical devices, healthcare IT, medical imaging, drug discovery, biotechnology and clinical diagnostics background that won '2009 India excellence in healthcare awards instituted by Frost& ...

This was posted under category: Pharma  |  Read Full Story  |  1 Comment

Injectable swine flu drug peramivir to treat complicated H1N1 round the corner

Wednesday, September 9, 2009 9:31

Paramivir is administered directly as intravenous (IV) injection, unlike oseltamivir pill and zanamivir inhaler

This was posted under category: health, Pharma  |  Read Full Story  |  2 Comments

Tovaxin keeps multiple scelorosis patients relapse-free, says Opexa

Wednesday, September 9, 2009 8:17

Tovaxin, a multiple sclerosis drug developed by Opexa Therapeutics Inc, keepsĀ  more than 83 percent of patients relapse-free after a year.

This was posted under category: health  |  Read Full Story  |  0 Comments